Back
ESC Premium Access

Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Session: Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?
Topic: Outcomes and Complications
Speaker: Professor G. Hindricks (Berlin, DE)
Event: ESC Congress 2018

Congress Presentation

About the speaker

Professor Gerhard Hindricks

Charite University Hospital, Berlin (Germany)
80 presentations
28 followers

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Speaker: Doctor D. Packer (Rochester, US)

Access
Slides
Video
Thumbnail

Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)

Access
Slides
Video
Thumbnail

Critical appraisal of the CABANA and CASTLE-AF trials.

Speaker: Professor I. Van Gelder (Groningen, NL)

Access
Slides
Video
Thumbnail

Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Professor G. Hindricks, Doctor D. Packer, Professor J. Brachmann, Professor I. Van Gelder
Access
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb